Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 41Leukemia 34Lymphoma 22Myelodysplastic Syndromes 16Hodgkin Disease 16Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Multiple Myeloma 10Lymphoma, Non-Hodgkin 10Lymphoma, Mantle-Cell 9Leukemia, Myeloid, Acute 9Recurrence 8Myeloproliferative Disorders 8Lymphoma, Large B-Cell, Diffuse 8Lymphoma, Follicular 8Lymphoma, B-Cell, Marginal Zone 8Leukemia, Myeloid, Chronic-Phase 7Anemia, Aplastic 7Waldenstrom Macroglobulinemia 6Lymphoma, T-Cell, Peripheral 6Congenital Abnormalities 6Burkitt Lymphoma 6Sezary Syndrome 5Primary Myelofibrosis 5Neoplasms, Plasma Cell 5Mycosis Fungoides 5Lymphoma, Large-Cell, Immunoblastic 5Graft vs Host Disease 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Myelodysplastic-Myeloproliferative Diseases 4Lymphoma, T-Cell, Cutaneous 4

Interventions

mogamulizumab 3Lenalidomide 2Gemcitabine 2peginterferon alfa-2b 1liposomal doxorubicin 1dolutegravir 1denileukin diftitox 1belinostat 1Zidovudine 1Tenofovir 1Taxes 1Panobinostat 1Paclitaxel 1Oxaliplatin 1Lomustine 1Irinotecan 1Introns 1Doxorubicin 1Dexamethasone 1Cytarabine 1Cyclophosphamide 1Cisplatin 1Carboplatin 1Calcium Dobesilate 1Alemtuzumab 1Albumin-Bound Paclitaxel 13-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Leukemia-Lymphoma, Adult T-Cell × Alemtuzumab × Clear all
NCT00061048 2012-10-31

Campath-1H for Treating Adult T-Cell Leukemia/Lymphoma

National Institutes of Health Clinical Center (CC)

Phase 2 Completed
29 enrolled 11 charts
LymphoidOther hematologic neoplasm

Leukemia-Lymphoma, Adult T-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡